| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Alessandro Serrett. Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder. International clinical psychopharmacology. vol 39. issue 6. 2024-09-27. PMID:39328148. |
venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder. |
2024-09-27 |
2024-09-29 |
Not clear |
| E Hoch, N D Volkow, C M Friemel, V Lorenzetti, T P Freeman, W Hal. Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits. European archives of psychiatry and clinical neuroscience. 2024-09-19. PMID:39299947. |
chronic patterns of cannabis use have been associated with multiple adverse outcomes that are of particular concern among adolescents and young adults, such as, disrupted learning, impaired cognitive performance, reduced educational attainment and an increased risk of cud, psychosis/schizophrenia, mood and anxiety disorders and suicidal behaviors. |
2024-09-19 |
2024-09-22 |
Not clear |
| Sasha Bailey, Ashleigh Lin, Angus Cook, Sam Winter, Vanessa Watson, Dani Wright Toussaint, Emma L Barrett, Nicola C Newton, Yael Perry, Lucinda Grummitt, Penelope Straus. Contextualising Experiences of Co-Occurring Mental Ill-Health and Substance Use Among Trans, Non-Binary, and Gender Diverse Young People: Implications for Tailored Harm Reduction Approaches. Community mental health journal. 2024-09-02. PMID:39222173. |
significantly increased odds of smoking or recent use of cannabis or sedatives was observed among trans young people reporting depressive disorder, anxiety disorder (aors ranging 1.8-3.1). |
2024-09-02 |
2024-09-04 |
Not clear |
| Stephen D S McCarthy, Jennifer Xiao, Michael Pugliese, Laurent Perrault-Sequeira, Daniel T Myra. Correction to "Changes in cannabis involvement in emergency department visits for anxiety disorders after cannabis legalization: a repeated cross-sectional study" - The Lancet Regional Health - Americas 2024; 36: 100815. Lancet regional health. Americas. vol 37. 2024-08-27. PMID:39188967. |
correction to "changes in cannabis involvement in emergency department visits for anxiety disorders after cannabis legalization: a repeated cross-sectional study" - the lancet regional health - americas 2024; 36: 100815. |
2024-08-27 |
2024-08-30 |
Not clear |
| Monica Madzoska, David Lawrence, Daryl J Higgins, Divna M Haslam, Ben Mathews, Eva Malacova, Michael P Dunne, Holly E Erskine, Rosana Pacella, Franziska Meinck, Hannah J Thomas, James G Scot. Child Maltreatment, Mental Health Disorders, and Health Risk Behaviors in People With Diverse Gender Identities. Journal of interpersonal violence. 2024-08-17. PMID:39152737. |
mental disorders-major depressive disorder, generalized anxiety disorder (gad), alcohol use disorder, post-traumatic stress disorder (ptsd), and health risk behaviors-smoking, binge drinking, cannabis dependence, self-harm, and suicide attempt in the past 12 months were assessed. |
2024-08-17 |
2024-08-20 |
Not clear |
| Keya Mallick, Mohd Faiz Khan, Sugato Banerje. The anxiolytic effects of cannabinoids: A comprehensive review. Pharmacology, biochemistry, and behavior. vol 243. 2024-07-21. PMID:39032530. |
cannabinoids, notably cannabidiol (cbd) and delta-9-tetrahydrocannabinol (thc), have emerged as promising candidates for anxiety disorder treatment, supported by both preclinical and clinical evidence. |
2024-07-21 |
2024-07-24 |
Not clear |
| João Luís Queiroz Simei, José Diogo Ribeiro de Souza, João Roberto Lisboa, Francisco Silveira Guimarães, José Alexandre de Souza Cripp. Cannabidiol in anxiety disorders: Current and future perspectives. International review of neurobiology. vol 177. 2024-07-19. PMID:39029985. |
cannabidiol in anxiety disorders: current and future perspectives. |
2024-07-19 |
2024-07-22 |
Not clear |
| João Luís Queiroz Simei, José Diogo Ribeiro de Souza, João Roberto Lisboa, Francisco Silveira Guimarães, José Alexandre de Souza Cripp. Cannabidiol in anxiety disorders: Current and future perspectives. International review of neurobiology. vol 177. 2024-07-19. PMID:39029985. |
since the 1970s, basic and clinical research on cannabidiol (cbd), a non-psychotomimetic compound found in the cannabis sativa plant, has indicated relevant anxiolytic effects, garnering attention for its therapeutic potential as an option in anxiety disorder treatment. |
2024-07-19 |
2024-07-22 |
Not clear |
| Stephen D S McCarthy, Jennifer Xiao, Michael Pugliese, Laurent Perrault-Sequeira, Daniel T Myra. Changes in cannabis involvement in emergency department visits for anxiety disorders after cannabis legalization: a repeated cross-sectional study. Lancet regional health. Americas. vol 36. 2024-07-08. PMID:38974381. |
we examined changes in emergency department (ed) visits for anxiety disorders with cannabis involvement in ontario, over a period that involved medical and non-medical cannabis legalization. |
2024-07-08 |
2024-07-11 |
Not clear |
| Stephen D S McCarthy, Jennifer Xiao, Michael Pugliese, Laurent Perrault-Sequeira, Daniel T Myra. Changes in cannabis involvement in emergency department visits for anxiety disorders after cannabis legalization: a repeated cross-sectional study. Lancet regional health. Americas. vol 36. 2024-07-08. PMID:38974381. |
changes in cannabis involvement in emergency department visits for anxiety disorders after cannabis legalization: a repeated cross-sectional study. |
2024-07-08 |
2024-07-11 |
Not clear |
| Stephen D S McCarthy, Jennifer Xiao, Michael Pugliese, Laurent Perrault-Sequeira, Daniel T Myra. Changes in cannabis involvement in emergency department visits for anxiety disorders after cannabis legalization: a repeated cross-sectional study. Lancet regional health. Americas. vol 36. 2024-07-08. PMID:38974381. |
one concern is that legalization of cannabis will result in increased cannabis use and in turn a higher prevalence of anxiety disorders. |
2024-07-08 |
2024-07-11 |
Not clear |
| Rebecca K Denson, Julia Brooks, Graziano Pinna, Natania A Cran. Effects of Cannabidiol in Adolescent and Young Adult Depressive and Anxiety Disorders: A Systematic Review of Clinical and Preclinical Research. Adolescent psychiatry (Hilversum, Netherlands). vol 13. issue 3. 2024-06-26. PMID:38919887. |
effects of cannabidiol in adolescent and young adult depressive and anxiety disorders: a systematic review of clinical and preclinical research. |
2024-06-26 |
2024-06-29 |
Not clear |
| Kevin Han, Jia-Yu Wang, Peng-Yun Wang, Yue-Chu-Han Pen. Therapeutic potential of cannabidiol (CBD) in anxiety disorders: A systematic review and meta-analysis. Psychiatry research. vol 339. 2024-06-26. PMID:38924898. |
therapeutic potential of cannabidiol (cbd) in anxiety disorders: a systematic review and meta-analysis. |
2024-06-26 |
2024-06-29 |
human |
| Daniel T Myran, Lyndsay D Harrison, Michael Pugliese, Peter Tanuseputro, Adrienne Gaudreault, Jess G Fiedorowicz, Marco Solm. Development of an anxiety disorder following an emergency department visit due to cannabis use: a population-based cohort study. EClinicalMedicine. vol 69. 2024-03-28. PMID:38544799. |
development of an anxiety disorder following an emergency department visit due to cannabis use: a population-based cohort study. |
2024-03-28 |
2024-03-30 |
Not clear |
| Daniel T Myran, Lyndsay D Harrison, Michael Pugliese, Peter Tanuseputro, Adrienne Gaudreault, Jess G Fiedorowicz, Marco Solm. Development of an anxiety disorder following an emergency department visit due to cannabis use: a population-based cohort study. EClinicalMedicine. vol 69. 2024-03-28. PMID:38544799. |
there is ongoing uncertainty about whether cannabis use increases the risk of developing an anxiety disorder. |
2024-03-28 |
2024-03-30 |
Not clear |
| Daniel T Myran, Lyndsay D Harrison, Michael Pugliese, Peter Tanuseputro, Adrienne Gaudreault, Jess G Fiedorowicz, Marco Solm. Development of an anxiety disorder following an emergency department visit due to cannabis use: a population-based cohort study. EClinicalMedicine. vol 69. 2024-03-28. PMID:38544799. |
in this study we estimated the risk of having an incident healthcare visit for an anxiety disorder following an emergency department (ed) visit for cannabis use and explored factors associated with increased risk. |
2024-03-28 |
2024-03-30 |
Not clear |
| Sonja Elsaid, Ruoyu Wang, Stefan Kloiber, Rebecca Haines-Saah, Ahmed N Hassan, Bernard Le Fol. Expectancies of the Effects of Cannabis Use in Individuals with Social Anxiety Disorder (SAD). Brain sciences. vol 14. issue 3. 2024-03-28. PMID:38539634. |
expectancies of the effects of cannabis use in individuals with social anxiety disorder (sad). |
2024-03-28 |
2024-03-30 |
Not clear |
| Sonja Elsaid, Ruoyu Wang, Stefan Kloiber, Rebecca Haines-Saah, Ahmed N Hassan, Bernard Le Fol. Expectancies of the Effects of Cannabis Use in Individuals with Social Anxiety Disorder (SAD). Brain sciences. vol 14. issue 3. 2024-03-28. PMID:38539634. |
previous research has indicated that anticipating positive effects from cannabis use may be linked with increased frequency of cannabis consumption, yet these expectancies remain poorly understood in adults with social anxiety disorder (sad). |
2024-03-28 |
2024-03-30 |
Not clear |
| Ankita Das, Christian S Hendershot, M Ishrat Husain, Yuliya Knyahnytska, Sonja Elsaid, Bernard Le Foll, Stefan Kloibe. Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannabis Program in Canada - A Qualitative Study. Pharmacopsychiatry. 2024-03-11. PMID:38467156. |
perceptions, experiences, and patterns of cannabis use in individuals with mood and anxiety disorders in the context of cannabis legalization and medical cannabis program in canada - a qualitative study. |
2024-03-11 |
2024-03-14 |
Not clear |
| Ankita Das, Christian S Hendershot, M Ishrat Husain, Yuliya Knyahnytska, Sonja Elsaid, Bernard Le Foll, Stefan Kloibe. Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannabis Program in Canada - A Qualitative Study. Pharmacopsychiatry. 2024-03-11. PMID:38467156. |
perceptions of cannabis as a potential medical treatment for mood and anxiety disorders have been increasing in the context of legalizations, availability, and medical cannabis programs, though current evidence predominately indicates risks and negative effects of cannabis use (cu) on mental health outcomes. |
2024-03-11 |
2024-03-14 |
Not clear |